Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17)

Annals of Neurology

Volumn 54, Issue 3, 2003, Pages 367-375

  Rolfs, Arndt ^a   Koeppen, Arnulf H ^b   Bauer, Ingrid ^a   Bauer, Peter ^c   Buhlmann, Sven ^a   Topka, Helge ^d   Schöls, Ludger ^e   Riess, Olaf ^c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Stratton VA Medical Center   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d KLINIKUM BOGENHAUSEN   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE; PROTEIN ANTIBODY; TATA BINDING PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAG REPEAT; CELL INCLUSION; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; GENE FREQUENCY; GENETIC CODE; GENETIC HETEROGENEITY; GRAY MATTER; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NERVE CELL NETWORK; NEUROPATHOLOGY; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCA17 GENE; SPINOCEREBELLAR DEGENERATION; TBP GENE; TISSUE DISTRIBUTION; TRINUCLEOTIDE REPEAT;

ADOLESCENT; ADULT; BRAIN; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MAGNETIC RESONANCE IMAGING; MALE; NEURONS; PEDIGREE; POLYMERASE CHAIN REACTION; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN; TRINUCLEOTIDE REPEATS;

EID: 0042837890     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10676     Document Type: Article

References (21)

1. Dürr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996;39:490-499.
2. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228.
3. Schöls L, Amoiridis G, Epplen JT, et al. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry 1996; 61:466-470.
4. Schöls L, Amoiridis G, Langkafel M, et al. Machado-Joseph disease mutations as the genetic basis of most spinocerebellar ataxias in Germany. J Neurol Neurosurg Psychiatry 1995;59: 449-450.
5. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000;23:217-247.
6. Margolis RL. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2002;2:447-456.
7. Koide R, Kobayashi S, Shimohata T, et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 1999;8:2047-2053.
8. Zühlke C, Hellenbroich Y, Dalski A, et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 2001;9:160-164.
9. Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001;10:1441-1448.
10. Fujigasaki H, Martin JJ, De Deyn PP, et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 2001;124:1939-1947.
11. Holmes SE, O'Hearn EE, McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 1999;23:391-392.
12. Schöls L, Amoiridis G, Buttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997;42:924-932.
13. Trottier Y, Zeder-Lutz G, Mandel JL. Selective recognition of proteins with parhological polyglutamine tracts by a monoclonal antibody. In: Wells RD, Warren ST, eds. Genetic instabilities and hereditary neurological diseases. San Diego: Academic Press, 1998:447-453.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Hisrochem Cytochem 1981;29:577-580.
15. Koeppen AH, Goedde HW, Hiller C, et al. Hereditary ataxia and the sixth chromosome. Arch Neurol 1981;38:158-164.
16. Silveira I, Miranda C, Guimaraes L, et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 2002;59:623-629.
17. Zühlke C, Gehlken U, Hellenbroich Y, et al. Phenotypical variability of expanded alleles in the TATA-binding protein gene. J Neurol 2003;250:161-163.
18. Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994;330: 1401-1406.
19. Schöls L, Peters S, Szymanski S, et al. Extrapyramidal motor signs in degenerative ataxias. Arch Neurol 2000;57:1495-1500.
20. Coutinho P, Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 1978;28:703-709.
21. Schwenkreis P, Tegenthoff M, Witscher K, et al. Motor cortex activation by transcranial magnetic srimulation in ataxia patients depends on the genetic defect. Brain 2002;125:301-309.